{"component": "definition", "props": {"groups": [{"size": 35, "samples": [{"hash": "hPAjJEccjqh", "uri": "/contracts/hPAjJEccjqh#jmc", "label": "Collaboration and License Agreement (Kura Oncology, Inc.)", "score": 36.1594810486, "published": true}, {"hash": "5xZ5IFkkmLQ", "uri": "/contracts/5xZ5IFkkmLQ#jmc", "label": "Definitive Collaboration Agreement (Vir Biotechnology, Inc.)", "score": 31.5920600891, "published": true}, {"hash": "dcH0KUh2zBt", "uri": "/contracts/dcH0KUh2zBt#jmc", "label": "Collaboration Agreement (Vir Biotechnology, Inc.)", "score": 31.5106086731, "published": true}], "snippet": "has the meaning set forth in Section 3.5.", "snippet_links": [{"key": "section-35", "type": "clause", "offset": [29, 40]}], "hash": "d96e1af961bb611d9ba7734312e69c3f", "id": 1}, {"size": 16, "samples": [{"hash": "ezQqtBfrucN", "uri": "/contracts/ezQqtBfrucN#jmc", "label": "Collaboration Agreement (Arvinas, Inc.)", "score": 32.553730011, "published": true}, {"hash": "aeeFDr6sD3n", "uri": "/contracts/aeeFDr6sD3n#jmc", "label": "Mrna Cancer Vaccine Collaboration and License Agreement (Moderna, Inc.)", "score": 29.8542098999, "published": true}, {"hash": "h8TvRT5YTfq", "uri": "/contracts/h8TvRT5YTfq#jmc", "label": "Mrna Cancer Vaccine Collaboration and License Agreement (Moderna, Inc.)", "score": 29.659822464, "published": true}], "snippet": "has the meaning set forth in Section 2.6(a).", "snippet_links": [], "hash": "7e47a71f473991ed364f5de5979792b5", "id": 2}, {"size": 12, "samples": [{"hash": "cX19nyaEfIy", "uri": "/contracts/cX19nyaEfIy#jmc", "label": "Development and Production Contract", "score": 29.3051738739, "published": true}, {"hash": "9eRG4StbyR9", "uri": "/contracts/9eRG4StbyR9#jmc", "label": "Development and Production Contract", "score": 29.3051738739, "published": true}, {"hash": "9N650NXx8M7", "uri": "/contracts/9N650NXx8M7#jmc", "label": "Development and Production Contract", "score": 29.3051738739, "published": true}], "snippet": "means the committee formed pursuant to Article 13.", "snippet_links": [{"key": "the-committee", "type": "clause", "offset": [6, 19]}, {"key": "article-13", "type": "clause", "offset": [39, 49]}], "hash": "deab201bb9c470175fa75d96c7ab8df0", "id": 3}, {"size": 12, "samples": [{"hash": "Qfubs7yLVc", "uri": "/contracts/Qfubs7yLVc#jmc", "label": "Development and License Agreement (Aderis Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "731Cidv890T", "uri": "/contracts/731Cidv890T#jmc", "label": "Development and License Agreement (Aderis Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "502MqU2ydqZ", "uri": "/contracts/502MqU2ydqZ#jmc", "label": "Development and License Agreement (Aderis Pharmaceuticals Inc)", "score": 18.0, "published": true}], "snippet": "means the Committee described in Section 3.3.", "snippet_links": [{"key": "the-committee", "type": "clause", "offset": [6, 19]}, {"key": "section-33", "type": "clause", "offset": [33, 44]}], "hash": "82b154e645c3951105dd06a83cb31032", "id": 4}, {"size": 9, "samples": [{"hash": "glAofkAEDur", "uri": "/contracts/glAofkAEDur#jmc", "label": "Option Agreement (ERHC Energy Inc)", "score": 21.0, "published": true}, {"hash": "fVuptGRJhIC", "uri": "/contracts/fVuptGRJhIC#jmc", "label": "Option Agreement (ERHC Energy Inc)", "score": 21.0, "published": true}, {"hash": "7bJ060pWAHz", "uri": "/contracts/7bJ060pWAHz#jmc", "label": "Administration Agreement (ERHC Energy Inc)", "score": 21.0, "published": true}], "snippet": "means the Joint Ministerial Council established pursuant to the Treaty;", "snippet_links": [{"key": "the-joint", "type": "definition", "offset": [6, 15]}, {"key": "ministerial-council", "type": "definition", "offset": [16, 35]}, {"key": "pursuant-to-the", "type": "definition", "offset": [48, 63]}], "hash": "7edd69c5410ddd408409c1955d2cf6c1", "id": 5}, {"size": 8, "samples": [{"hash": "83WWYAOgLcb", "uri": "/contracts/83WWYAOgLcb#jmc", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 35.1409988403, "published": true}, {"hash": "l3SeuC4QJiw", "uri": "/contracts/l3SeuC4QJiw#jmc", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 34.1444206238, "published": true}, {"hash": "3ebf1sSqNAi", "uri": "/contracts/3ebf1sSqNAi#jmc", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 31.5790557861, "published": true}], "snippet": "has the meaning set forth in Section 9.4.1.", "snippet_links": [{"key": "section-941", "type": "clause", "offset": [29, 42]}], "hash": "52ca8b8f9133c46cfdfb2cecbed32ed7", "id": 6}, {"size": 7, "samples": [{"hash": "TcNclVnwbe", "uri": "/contracts/TcNclVnwbe#jmc", "label": "Loan and Security Agreement (Aerocentury Corp)", "score": 29.3408622742, "published": true}, {"hash": "gt7svC0K5lW", "uri": "/contracts/gt7svC0K5lW#jmc", "label": "Merger Agreement (Aerocentury Corp)", "score": 28.8275146484, "published": true}, {"hash": "gKz2kmO7mUo", "uri": "/contracts/gKz2kmO7mUo#jmc", "label": "Loan and Security Agreement (Aerocentury Corp)", "score": 28.2101306915, "published": true}], "snippet": "means JetFleet Management Corp., a California corporation.", "snippet_links": [{"key": "management-corp", "type": "clause", "offset": [15, 30]}, {"key": "california-corporation", "type": "definition", "offset": [35, 57]}], "hash": "f7b162d454e30ab06fbb76829b7f2c76", "id": 7}, {"size": 7, "samples": [{"hash": "65Tpka9XIGr", "uri": "/contracts/65Tpka9XIGr#jmc", "label": "Collaboration and License Agreement (Alder Biopharmaceuticals Inc)", "score": 25.3285427094, "published": true}, {"hash": "7chJJsaFsS2", "uri": "/contracts/7chJJsaFsS2#jmc", "label": "Collaboration Agreement (Medivation, Inc.)", "score": 25.2245044708, "published": true}, {"hash": "hmRsDoxl6P3", "uri": "/contracts/hmRsDoxl6P3#jmc", "label": "Collaboration and License Agreement (Alder Biopharmaceuticals Inc)", "score": 25.2108154297, "published": true}], "snippet": "means the committee formed by the Parties as described in Section 2.4(a).", "snippet_links": [{"key": "the-committee", "type": "clause", "offset": [6, 19]}, {"key": "by-the-parties", "type": "clause", "offset": [27, 41]}], "hash": "087d462c84900c6f33a62da1a9dd0bc1", "id": 8}, {"size": 7, "samples": [{"hash": "3fsRoRWfyDQ", "uri": "/contracts/3fsRoRWfyDQ#jmc", "label": "Collaboration Agreement (Orexigen Therapeutics, Inc.)", "score": 27.0287475586, "published": true}, {"hash": "7als5PKXHHD", "uri": "/contracts/7als5PKXHHD#jmc", "label": "Collaboration Agreement (Orexigen Therapeutics, Inc.)", "score": 26.8535251617, "published": true}, {"hash": "b8dDTgqsBO4", "uri": "/contracts/b8dDTgqsBO4#jmc", "label": "Collaboration Agreement (Orexigen Therapeutics, Inc.)", "score": 21.8405208588, "published": true}], "snippet": "has the meaning set forth in Section 5.4.1.", "snippet_links": [], "hash": "2635c467d5df3dc33c26967dc9700c39", "id": 9}, {"size": 7, "samples": [{"hash": "fy1KL448wUe", "uri": "/contracts/fy1KL448wUe#jmc", "label": "Collaboration and License Agreement (Sucampo Pharmaceuticals, Inc.)", "score": 21.0, "published": true}, {"hash": "fbffL2QHwh5", "uri": "/contracts/fbffL2QHwh5#jmc", "label": "Collaboration and License Agreement (Sucampo Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "snippet": "shall have the meaning set forth in Section 6.1(a).", "snippet_links": [], "hash": "56b19a94606d748f76bb99e08c990aee", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMam1jIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 267, "title": "JMC", "snippet": "has the meaning set forth in Section 3.5.", "id": "jmc", "examples": ["The <strong>JMC</strong> will immediately disband and terminate upon the earliest of (i) expiration or termination of this Agreement in its entirety, (ii) the Opt-Out Effective Date (or, if later, the expiration of the Vir Bio Manufacturing Period), and (iii) upon the end of the U.S. P&amp;L Share Term.", "Once agreed, the <strong>JMC</strong> will submit the CMC Budget to the JDC for review, approval and inclusion in the Shared Development Plan and Budget.", "Promptly following the Effective Date, the <strong>JMC</strong> will meet, discuss and prepare a budget setting forth the FTE Costs and Out-of-Pocket Costs the Parties anticipate incurring in connection with CMC Development for Licensed Compounds and Licensed Products (the \u201cCMC Budget\u201d).", "The Parties may establish other (sub)committees or working groups as may be necessary or desirable to facilitate the activities under this Agreement or an Ancillary Agreement (together with the JSC, the JDC, the JCC, the <strong>JMC</strong>, and the JIPC, each, a \u201cCommittee\u201d), with functions and authorities consistent with the terms and provisions of this Agreement and any Ancillary Agreement.", "No amendment, modification, or supplement of or to this Agreement shall be binding upon the Parties unless in writing and duly executed by authorized representatives of both Parties, except that amendments and updates to the Shared Development Plan and Budget, Transition Plan, Manufacturing Technology Transfer Plan, or Joint Manufacturing Plan shall be binding upon approval by the JSC or <strong>JMC</strong>, as applicable.", "Each Party may change its respective representatives to the <strong>JMC</strong> from time to time, in its sole discretion, effective upon notice to the other Party designating such change.", "The <strong>JMC</strong> will be comprised of two representatives of Company and two representatives of Vir Bio (or such other equal number of representatives as the <strong>JMC</strong> may determine).", "The Alliance Managers or their designees will attend <strong>JMC</strong> meetings in a non-voting capacity.", "Each Party\u2019s <strong>JMC</strong> representatives will have appropriate business credentials, experience, and knowledge pertaining to, and ongoing familiarity with, the terms of this Agreement and the activities to be conducted in connection with this Agreement, and at least one such representative will also have appropriate seniority, experience, and authority to make decisions on behalf of the Parties with respect to issues falling within the jurisdiction of the <strong>JMC</strong>.", "The <strong>JMC</strong> shall coordinate and manage the Manufacturing Technology Transfer."], "related": [["jcc", "JCC", "JCC"], ["jsc", "JSC", "JSC"], ["jdc", "JDC", "JDC"], ["jrc", "JRC", "JRC"], ["steering-committee", "Steering Committee", "Steering Committee"]], "related_snippets": [], "updated": "2026-05-10T05:39:37+00:00"}, "json": true, "cursor": ""}}